New cell lines with chondrocytic phenotypes from human chondrosarcoma

Virchows Archiv

Volumn 444, Issue 6, 2004, Pages 577-586

  Kudawara, Ikuo ^a   Araki, Nobuhito ^b   Myoui, Akira ^c   Kato, Yoichi ^d   Uchida, Atsumasa ^e   Yoshikawa, Hideki ^c  

^a OSAKA NATIONAL HOSPITAL   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d ASAHI KASEI PHARMA CORPORATION   (Japan)

^e MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cell line; Chondrosarcoma; Matrix metalloproteinase; Proteoglycan; Type II collagen

Indexed keywords

AGGRECAN; COLLAGEN TYPE 1; COLLAGEN TYPE 10; COLLAGEN TYPE 11; COLLAGEN TYPE 2; GELATINASE A; GELATINASE B; MESSENGER RNA;

ARTICLE; CARCINOGENICITY; CARTILAGE CELL; CELL CLONING; CELL LEVEL; CELL LINE; CELL PROLIFERATION; CHONDROSARCOMA; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 3042847454     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-004-1020-6     Document Type: Article

References (50)

1. Aigner T, Dertinger S, Vornehm SI, Dudhia J, von der Mark K, Kirchner T (1997) Phenotypic diversity of neoplastic chondrocytes and extracellular matrix gene expression in cartilaginous neoplasm. Am J Pathol 150:2133-2141
2. Aigner T, Müller S, Neureiter D, Illstrup DM, Kirchner T, Björnson J (2002) Prognostic relevance of cell biologic and biochemical features in conventional chondrosarcomas. Cancer 94:2273-2281
3. Berend KR, Toth AP, Harrelson JM, Layfield LJ, Hey LA, Scully SP (1998) Association between ratio of matrix metalloproteinase-1 to tissue inhibitor of metalloproteinase-1 and local recurrence, metastasis, and survival in human chondrosarcoma. J Bone Joint Surg Am 80:11-17
4. Block JA, Inerot S, Gitelis S, Kimura JH (1991) Synthesis of chondrocytic keratan sulphate-containing proteoglycans by human chondrosarcoma cells in long-term cell culture. J Bone Joint Surg Am 73:647-658
5. 35-sulfate in chondrosarcomatous tissue. Acta Orthop Scandinav 39:58-72
6. Bridge JA, Bhatia PS, Anderson JR, Neff JR (1993) Biologic and clinical significance of cytogenetic and molecular cytogenetic abnormalities in benign and malignant cartilaginous lesions. Cancer Genet Cytogenet 69:79-90
7. Burgeson R (1998) New collagens, new concepts. Ann Rev Cell Biol 4:551-577
8. Burgeson RE, Hollister DW (1979) Collagen heterogeneity in human cartilage: identification of several new collagen chains. Biochem Biopys Res Commun 87:1124-1131
9. Chandrasekhar S, Esterman M, Hoffman HA (1987) Microdetermination of proteoglycans and glycosaminoglycans in the presence of guanidine hydrochloride. Anal Biochem 161:103-108
10. Chano T, Okabe H, Saeki Y, Ishizawa M, Matsumoto K, Hukuda S (1998) Characterization of a newly established human chondrosarcoma cell line, CS-OKB. Virchows Arch 432: 529-534
11. Chansky H, Robbins JR, Cha S, Raskind WH, Conrad EU, Sandell LJ (1998) Expression of cartilage extracellular matrix and potential regulatory genes in a new human chondrosarcoma cell line. J Ortop Res 16:521-530
12. Dijkhuizen T, Berg E, Molenaar WM, Oosterhuis JW, Dam A, Wiersema J, Koops H, de Jong B (1994) Cytogenetics as a tool in the histologic subclassification of chondrosarcoma. Cancer Genet Cytogenet 76:100-105
13. Elima K, Vuorio E (1989) Expression of mRNAs for collagens and other matrix components in dedifferentiating and redifferentiating human chondrocytes in culture. FEBS Lett 258:195-198
14. Evans HL, Ayala AG, Romsdahl MM (1977) Prognostic factors in chondrosarcoma of bone. A clinicopathologic analysis with emphasis on histologic grading. Cancer 40:818-831
15. Fletcher JA, Lipinski KK, Weidner N, Morton CC (1989) Complex cytogenetic aberrations in a well-differentiated chondrosarcoma. Cancer Genet Cytogenet 41:115-121
16. Gil-Benso R, Lopez-Gines C, López-Guerrero JA, Carda C, Callaghan RC, Navarro S, Ferrer J, Pellín A, Llombart-Bosch A (2003) Establishment and characterization of a continuous human chondrosarcoma cell line, ch-2879: comparative histologic and genetic studies with its tumor of origin. Lab Invest 83:877-887
17. Gowen M, Wood DD, Ihrie EJ, Meats JE, Russell RGG (1984) Stimulation by human interleukin 1 of cartilage breakdown and production of collagenase and proteoglycanase by human chondrocytes but not by human osteoblasts in vitro. Biochim Biophys Acta 797:186-193
18. Herwig J, Roessner A, Buddecke E (1986) Isolation and characterization of proteoglycans and glycosaminoglycans from human chondrosarcoma. Exp Mol Pathol 45:118-127
19. Hirabayashi Y, Yoshida MA, Ikeuchi T, Ishida T, Kojima T, Higaki S, Machinami R, Tonomura A (1992) Chromosomal rearrangements at 12q13 in two cases of chondrosarcomas. Cancer Genet Cytogenet 60:35-40
20. Huvos AG (1991) Chondrosarcoma including spindle-cell (dedifferentiated) and myxoid chondrosarcoma; mesenchymal chondrosarcoma. In: Huvos AG (ed) Bone tumors. W.B. Saunders Company, Philadelphia, pp 343-381
21. Kaplan D, Meyer K (1959) Ageing of human cartilage. Nature (London) 183:1267-1268
22. Kawashima A, Ueda Y, Tsuchiya H, Tomita K, Nagai Y, Nakanishi I (1993) Immunohistochemical localization of collagenous proteins in cartilaginous tumors: characteristic distribution of type IX collagen. J Cancer Res Clin Oncol 120:35-40
23. Kawashima A, Okada Y, Nakanishi I, Ueda Y, Iwata K, Roessner A (1997) Immunolocalization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human chondrosarcomas. Gen Diagn Pathol 142:129-137
24. Kunisada T, Miyazaki M, Mihara K, Gao C, Kawai A, Inoue H, Namba M (1998) A new human chondrosarcoma cell line (OUMS-27) that maintains chondrocytic differentiation. Int J Cancer 77:854-859
25. Lee FY, Mankin HJ, Fondren G, Gebhardt MC, Springfield DS, Rosenberg, AE, Jennigs, LC (1999) Chondrosarcoma of bone: an assessment of outcome. J Bone Joint Surg Am 81:326-337
26. Mandahl N, Heim S, Arheden K, Rydholm A, Willén H, Mitelman F (1990) Chromosomal rearrangements in chondromatous tumors. Cancer 65:242-248
27. Mankin HJ, Cantley KP, Lippiello L, Schiller AL, Campbell CJ (1980) The biology of human chondrosarcoma. I. Description of the cases, grading, and biochemical analyses. J Bone Joint Surg Am 62:160-175
28. Mankin HJ, Cantley KP, Schiller AL, Lippiello L (1980) The biology of human chondrosarcoma. II. Variation in chemical composition among types and subtypes of benign and malignant cartilage tumors. J Bone Joint Surg Am 62:176-188
29. Mathews MB, Glacov S (1966) Acid mucopolysaccharide patterns in aging human cartilage. J Clin Invest 45:1103-1111
30. Miller E, Gay S (1987) The collagens: an overview and update. In: Colowick SP and Kaplan NO (eds) Methods in enzymology. 144 Academic Press, Inc., London, pp 3-41
31. Mirra JM, Eckardt JJ (1989) Enchondroma versus chondrosarcoma. In: Mirra JM (ed) Bone tumors. Lea & Febiger, Philadelphia, pp 476-535
32. Morris NP, Bächinger HP (1987) Type XI collagen is a heterotrimer with the composition (1 alpha, 2 alpha, 3 alpha) retaining non-triple-helical domains. J Biol Chem 262:11345-11350
33. Mourão PAS, Rozenfeld S, Laredo J, Dietrich CP (1976) The distribution of chondroitin sulfates in articular and growth cartilage of human bones. Biochem Biophys Acta 428:19-26
34. Mourão PAS, Michelacci YM, Toledo OMS (1979) Glycosaminoglycans and proteoglycans of normal and tumoral cartilages of humans and rats. Cancer Res 39:2802-2806
35. Müller PK, Lemmen C, Gay S, Gauss V, Kühn K (1977) Immunochemical and biochemical study of collagen synthesis by chondrocytes in culture. Exp Cell Res 108:47-55
36. Nakamura Y, Becker LE, Marks A (1983) S-100 protein in tumors of cartilage and bone. 52:1820-1824
37. Okada Y, Shinmei M, Tanaka O, Naka K, Kimura A, Nakanishi I, Bayliss MT, Iwata K, Nagase H (1992) Localization of matrix metalloproteinase3 (stromelysin) in osteoarthritic cartilage and synovium. Lab Invest 66:680-690
38. Okajima K, Honda I, Kitagawa T (1988) Immunohistochemical distribution of S-100 protein in tumors and tumor-like lesions of bone and cartilage. Cancer 61:792-799
39. Powell WC, Matrisian LM (1996) Complex roles of matrix metalloproteinases in tumor progression. In: Günthert U, Birchmeier W (eds) Attempts to understand metastasis formation I. Springer Verlag, Berlin Heidelberg New York, pp 1-21
40. Saito S, Katoh M, Matsumoto M, Matsumoto S, Masuho Y (1997) Collagen degradation induced by the combination of IL-1 alpha and plasminogen in rabbit articular cartilage explant culture. J Biochem 122:49-54
41. Sakamoto A, Oda Y, Iwamoto Y, Tsuneyoshi M (1999) Expression of membrane type 1 matrix metalloproteinase, matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 in human cartilaginous tumors with special emphasis on mesenchymal and dedifferentiated chondrosarcoma. J Cancer Res Clin Oncol 125:541-548
42. Sheth DS, Yasko AW, Johnson ME, Alaya AG, Murray JA, Romsdahl MM (1996) Chondrosarcoma of the pelvis. Prognostic factors for 67 patients treated with definitive surgery. Cancer 15:745-750
43. Shinmei M, Masuda K, Kikuchi T, Shimomura Y (1989) The role of cytokines in chondrocyte mediated cartilage degradation. J Rheumatol 16[Suppl]:32-34
44. Sweet MBE, Thonar EJAL, Immelman AR (1976) Glycosaminoglycans and proteoglycans of human chondrosarcoma. Biochem Biophys Acta 437:71-86
45. Takigawa M, Tajima K, Pan HO, Enomoto M, Kinoshita A, Suzuki F, Takano Y, Mori Y (1989) Establishment of a clonal human chondrosarcoma cell line with cartilage phenotypes. Cancer Res 49:3996-4002
46. Thonar EJA, Sweet MBE, Immelman AR, Lyons G (1979) Structural studies on proteoglycan from human chondrosarcoma. Arch Biochem Biophys 194:179-189
47. Ueda Y, Oda Y, Tsuchiya H, Tomita K, Nakanishi I (1990) Immunohistological study on collagenous proteins of benign and malignant human cartilaginous tumours of bone. Virchows Archiv 417:291-297
48. Unni KK (1996) Chondrosarcoma. In: Unni KK (ed) Dahlin's bone tumors. Lippincott-Raven, Philadelphia, pp 71-108
49. Uría JA, Balbín M, López JM, Alvares J, Vizoso F, Takigawa M, López-Otín C (1998) Collagenase-3 (MMP-13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor. Am J Pathol 153:91-101
50. Weiss APC, Dorfman HD (1986) S-100 protein in human cartilage lesions. J Bone Joint Surg Am 68:521-526